Forte Biosciences Statistics

Total Valuation

FBRX has a market cap or net worth of $47.50 million. The enterprise value is -$8.75 million.

Market Cap	47.50M
Enterprise Value	-8.75M

Important Dates

The last earnings date was Monday, March 31, 2025, before market open.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

FBRX has 6.39 million shares outstanding. The number of shares has increased by 130.90% in one year.

Current Share Class	6.39M
Shares Outstanding	6.39M
Shares Change (YoY)	+130.90%
Shares Change (QoQ)	+231.63%
Owned by Insiders (%)	8.82%
Owned by Institutions (%)	45.10%
Float	3.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.95
P/TBV Ratio	0.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.76

Current Ratio	6.76
Quick Ratio	6.43
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -80.82% and return on invested capital (ROIC) is -52.11%.

Return on Equity (ROE)	-80.82%
Return on Assets (ROA)	-45.51%
Return on Invested Capital (ROIC)	-52.11%
Return on Capital Employed (ROCE)	-69.74%
Revenue Per Employee	n/a
Profits Per Employee	-$3.94M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.00% in the last 52 weeks. The beta is 2.86, so FBRX's price volatility has been higher than the market average.

Beta (5Y)	2.86
52-Week Price Change	-58.00%
50-Day Moving Average	10.13
200-Day Moving Average	11.38
Relative Strength Index (RSI)	44.67
Average Volume (20 Days)	54,417

Short Selling Information

The latest short interest is 13,690, so 0.21% of the outstanding shares have been sold short.

Short Interest	13,690
Short Previous Month	12,455
Short % of Shares Out	0.21%
Short % of Float	0.40%
Short Ratio (days to cover)	0.62

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-36.60M
Pretax Income	-32.14M
Net Income	-35.48M
EBITDA	-36.56M
EBIT	-36.60M
Earnings Per Share (EPS)	-$12.17

Full Income Statement

Balance Sheet

The company has $58.37 million in cash and n/a in debt, giving a net cash position of $58.37 million or $9.13 per share.

Cash & Cash Equivalents	58.37M
Total Debt	n/a
Net Cash	58.37M
Net Cash Per Share	$9.13
Equity (Book Value)	52.48M
Book Value Per Share	8.21
Working Capital	52.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$30.75 million and capital expenditures -$37,000, giving a free cash flow of -$30.78 million.

Operating Cash Flow	-30.75M
Capital Expenditures	-37,000
Free Cash Flow	-30.78M
FCF Per Share	-$4.81

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-130.90%
Shareholder Yield	-130.90%
Earnings Yield	-71.51%
FCF Yield	-62.05%

Analyst Forecast

The average price target for FBRX is $77.58, which is 944.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$77.58
Price Target Difference	944.15%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-17.70%

Stock Forecasts

Stock Splits

The last stock split was on August 28, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Aug 28, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1